Ebeling Thomas 4
4 · Cullinan Oncology, Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Ebeling Thomas
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+16,475→ 16,475 totalExercise: $12.73Exp: 2032-06-21→ Common Stock (16,475 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 16,475 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.